No influence of sarcopenia on survival of ovarian cancer patients in a prospective validation study

Jorne Ubachs, Simone N. Koole, Max Lahaye, Cristina Fabris, Leigh Bruijs, Jules Schagen van Leeuwen, Henk W. R. Schreuder, R. H. Hermans, I. H. de Hingh, J. van der Velden, H. J. Arts, M. van Ham, P. van Dam, P. Vuylsteke, Jacco Bastings, Roy F. P. M. Kruitwagen, Sandrina Lambrechts, Steven W. M. Olde Damink, Sander S. Rensen, Toon Van GorpGabe S. Sonke, Willemien J. van Driel*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

32 Downloads (Pure)
Original languageEnglish
Pages (from-to)706-711
Number of pages6
JournalGynecologic Oncology
Volume159
Issue number3
DOIs
Publication statusPublished - Dec 2020

Keywords

  • Sarcopenia
  • Ovarian cancer
  • Cachexia
  • Survival
  • OVHIPEC
  • NEOADJUVANT CHEMOTHERAPY
  • BODY-COMPOSITION
  • SKELETAL-MUSCLE
  • PREDICTOR
  • SURGERY

Cite this